Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole prophylaxis in children with chronic granulomatous disease
NL-OMON32626Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of posaconazole in chronic granulomatous disease (CGD), sponsored by Radboud University Medical Center. Primary endpoint: Posaconazole trough plasma concentrations. Started Oct 2008; status: active, not recruiting.
02
Drugs
posaconazole
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on NL-OMON32626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32626.